Evidence Hub

Infantile tremor syndrome with megaloblastic anaemia – A case series

Leena Singhal, V. Ganesh

Karnataka Paediatric Journal, 2026

Abstract

Infantile tremor syndrome (ITS) is a self-limiting clinical condition primarily affecting infants. It is characterised by a constellation of symptoms, including coarse tremors, often exacerbated by wakefulness and mitigated during sleep, anaemia, distinctive skin pigmentation changes, developmental regression and hypotonia in seemingly well-nourished infants. While a definitive aetiology remains elusive, various hypotheses have been proposed, including infectious, metabolic and nutritional factors. A growing body of evidence implicates Vitamin B12 deficiency as a significant contributor to ITS pathogenesis, though this association remains a subject of ongoing debate. In the absence of a conclusive diagnosis, empirical management often involves a multifaceted approach. Nutritional supplementation with iron, calcium, magnesium, Vitamin B12 and other essential micronutrients is a cornerstone of treatment. Pharmacotherapy, primarily with propranolol, may be employed to alleviate tremors, though other anticonvulsants such as phenobarbital, phenytoin and carbamazepine may be considered in refractory cases.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free